v3.26.3
Consolidated Statements of Operations (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
OPERATING EXPENSES        
Research and development $ 5,973,075 $ 3,755,335 $ 19,399,234 $ 7,563,988
General and administrative 3,061,583 3,124,260 8,378,974 9,153,821
Loss from operations (9,034,658) (6,879,595) (27,778,208) (16,717,809)
OTHER (EXPENSE) INCOME        
Interest income 15,999 65 16,090 195
Interest expense (621,298) (702,223)
Loss on extinguishment of debt (1,639,319) (1,639,319)
Non-operating income 76,228 76,228
Non-operating expenses (76,114) (280,947)
Change in fair value of warrant liability 1,424,603
TOTAL OTHER (EXPENSE) INCOME (2,244,504) 65 (2,530,171) 1,424,798
NET LOSS (11,279,162) (6,879,530) (30,308,379) (15,293,011)
NET LOSS available to common shareholders $ (11,279,162) $ (6,879,530) $ (30,308,379) $ (15,293,011)
Weighted-average number of shares 48,062,253 31,956,686 45,104,994 27,390,472
Basic loss per common share outstanding (in Dollars per share) $ (0.23) $ (0.22) $ (0.67) $ (0.56)
Diluted loss per common share outstanding (in Dollars per share) $ (0.23) $ (0.22) $ (0.67) $ (0.56)

Source